chronic
myeloid
leukemia
cml
character
accumul
activ
bcrabl
protein
imatinib
firstlin
treatment
cml
howev
mani
patient
resist
drug
studi
aim
compar
differ
express
pattern
function
timeseri
gene
imatinibresist
cml
cell
differ
drug
treatment
download
geo
databas
includ
sampl
cell
without
drug
administr
three
drug
treatment
group
consid
studi
arsen
trioxid
ato
group
one
sampl
time
point
h
timeseri
gene
ratio
standard
deviationaverag
coeffici
variat
screen
express
pattern
reveal
base
short
timeseri
express
miner
stem
function
enrich
analysi
timeseri
gene
group
perform
use
david
gene
enrich
top
ten
function
categori
extract
detect
express
pattern
differ
timeseri
gene
identifi
three
group
enrich
ribosom
oxid
phosphoryl
pathway
timeseri
gene
three
treatment
group
differ
express
pattern
function
timeseri
gene
ato
group
eg
significantli
associ
cell
adhes
group
relat
cellular
carbohydr
metabol
process
group
eg
significantli
relat
cell
prolifer
antigen
process
imatinibresist
cml
cell
ato
could
influenc
gene
relat
cell
adhes
might
affect
gene
involv
cellular
carbohydr
metabol
combin
therapi
might
regul
gene
involv
cell
prolifer
bcrabl
protein
howev
patient
bcrablindepend
imatinib
resist
provid
desir
health
benefit
sever
factor
crucial
mainten
cml
stem
cell
promyelocyt
leukemia
pml
identifi
inhibit
factor
combin
tki
agent
could
success
erad
tki
resist
cml
stem
cell
arsen
trioxid
ato
anticanc
agent
use
combin
cytarabin
arac
proven
decreas
express
pml
synergist
effect
ato
imatinibresist
cml
cell
via
induct
endoplasm
reticulum
stressmedi
apoptosi
demonstr
recent
report
studi
combin
aforement
drug
inhibit
cell
prolifer
patient
cml
blast
crisi
phase
despit
provid
valuabl
find
previou
studi
focu
simultan
comparison
molecular
chang
among
ato
combin
treatment
identif
timeseri
gene
help
uncov
mechan
underli
transcript
regul
present
studi
reanalyz
dataset
establish
xia
et
al
contain
cml
sampl
differ
time
point
three
treatment
ato
combin
therapi
compar
gene
express
pattern
three
treatment
moreov
function
pathway
enrich
analys
intend
screen
potenti
gene
marker
specif
function
pathway
obtain
better
guidelin
target
therapi
cml
three
treatment
respect
transcript
profil
download
gene
express
omnibu
geo
http
wwwncbinlmnihgovgeo
databas
base
hissib
human
cdna
array
platform
sampl
dataset
includ
cell
without
drug
administr
cell
treat
ato
ato
group
group
combin
group
cultur
h
respect
one
sampl
present
group
time
point
raw
data
express
profil
preprocess
use
r
softwar
bioconductor
http
wwwbioconductororg
first
probe
convert
gene
symbol
nonexpress
probe
filter
multipl
probe
correspond
gene
valu
averag
obtain
gene
express
averag
valu
standard
deviat
sd
gene
express
four
time
point
calcul
group
gene
ratio
sdaverag
valu
greater
defin
timeseri
gene
onlin
tool
databas
annot
visual
integr
discoveri
david
http
davidabccncifcrfgov
employ
perform
pathway
enrich
analysi
timeseri
gene
base
kyoto
encyclopedia
gene
genom
kegg
http
wwwgenomejpkeggpathwayhtml
databas
raw
pvalu
adjust
control
fals
discoveri
rate
fdr
use
benjaminihochberg
bh
method
fdr
less
consid
cutoff
signific
pathway
categori
short
timeseri
express
miner
stem
softwar
use
cluster
gene
coher
chang
pvalu
set
threshold
signific
express
pattern
afterward
differ
express
pattern
timeseri
gene
three
treatment
group
compar
gene
ontolog
go
http
wwwgeneontologyorg
enrich
analysi
becom
common
approach
function
annot
largescal
genom
data
function
enrich
analysi
timeseri
gene
carri
identifi
signific
gene
express
pattern
go
function
categori
consid
signific
p
valu
less
top
ten
signific
go
categori
identifi
timeseri
gene
categori
extract
determin
express
pattern
base
aforement
method
timeseri
gene
leukemia
cell
line
identifi
three
differ
treatment
group
gene
ato
group
gene
group
gene
group
venn
diagram
show
timeseri
gene
overlap
three
treat
group
fig
pathway
fdr
less
consid
signific
tabl
found
timeseri
gene
three
group
enrich
similar
pathway
ribosom
oxid
phosphoryl
pathway
comparison
express
pattern
timeseri
gene
reveal
differ
among
three
group
notabl
mani
timeseri
gene
ato
group
similar
express
pattern
eg
gene
profil
howev
similar
express
pattern
found
among
three
group
particular
gene
express
pattern
profil
group
markedli
differ
two
group
addit
gene
express
pattern
profil
significantli
differ
ato
group
timeseri
gene
profil
show
stableincreasingst
express
trend
atoamn
group
wherea
present
stableincreasingdecreas
express
trend
two
group
profil
timeseri
gene
show
increasingdecreas
express
trend
group
wherea
exhibit
increasingstableincreasingdecreas
trend
two
group
profil
timeseri
gene
present
increasingstableincreas
express
trend
group
wherea
exhibit
increasingdecreas
trend
ato
group
fig
tabl
color
profil
repres
signific
profil
top
ten
go
categori
timeseri
gene
select
base
go
enrich
analysi
express
pattern
timeseri
gene
enrich
ten
go
categori
identifi
tabl
observ
ato
group
enrich
function
categori
associ
posit
regul
cell
adhes
neg
regul
dna
bind
express
pattern
profil
exhibit
increasingdecreas
trend
addit
timeseri
gene
enrich
cellcel
adhes
go
categori
exhibit
express
pattern
profil
show
increas
trend
initi
remain
stabl
tabl
group
timeseri
gene
significantli
associ
neg
regul
cellular
carbohydr
metabol
process
chemokin
receptor
bind
reveal
increasingstableincreasingdecreas
profil
express
trend
timeseri
gene
significantli
correl
peptidas
activ
act
lamino
acid
peptid
chlorid
channel
complex
peptidas
activ
function
show
increasingstableincreasingdecreas
express
trend
profil
tabl
group
timeseri
gene
associ
antigen
process
present
neural
signal
transmiss
show
increasingdecreasingst
express
trend
profil
timeseri
gene
enrich
neg
regul
cell
prolifer
present
stableincreasingst
express
trend
profil
tabl
notabl
ato
group
seven
timeseri
gene
podxl
ptma
significantli
enrich
cell
adhes
show
increasingdecreas
express
trend
profil
group
five
timeseri
gene
cltc
significantli
associ
antigen
process
present
peptid
antigen
via
mhc
class
present
increasingdecreasingst
express
pattern
profil
tabl
studi
differ
timeseri
gene
differ
express
pattern
identifi
treatment
ato
combin
two
drug
respect
among
gene
group
notic
differ
express
pattern
compar
timeseri
gene
two
group
profil
addit
express
chang
trend
profil
differ
ato
group
combin
group
enrich
analysi
show
timeseri
gene
signific
express
pattern
differ
function
differ
treatment
group
ato
group
timeseri
gene
eg
associ
cell
adhes
function
present
increasingdecreas
trend
profil
combin
group
timeseri
gene
significantli
associ
serin
famili
amino
acid
metabol
process
present
increasingstableincreas
trend
profil
group
timeseri
gene
express
pattern
similar
profil
stableincreasingdecreas
reveal
signific
associ
cellular
carbohydr
metabol
process
wherea
group
timeseri
gene
profil
stableincreasingst
pronouncedli
associ
neg
regul
cell
prolifer
addit
timeseri
gene
eg
mainli
enrich
antigen
processingrel
function
found
present
increasingdecreasingst
express
trend
profil
differ
express
pattern
timeseri
gene
ato
group
group
could
explain
differ
gene
function
cell
cell
adhes
signal
implic
cml
sever
gene
pathway
upregul
cml
hematopoiet
stem
cell
cell
cyclerel
gene
mainli
function
g
g
phase
cml
express
protein
downregul
imatinib
administr
alon
combin
arsen
sulfid
cell
cyclerel
gene
also
function
cell
adhes
instanc
cell
cyclerel
gene
report
promot
cell
adhes
howev
cell
adhes
activ
cell
cycl
progress
cell
cycl
cell
adhes
regul
enzym
observ
collect
suggest
close
relationship
two
cellular
activ
notabl
ato
compel
cmliniti
cell
lic
enter
cell
cycl
downregul
pml
express
process
enhanc
drug
sensit
cml
cell
find
reveal
ato
administr
might
erad
tki
resist
cml
cell
regul
cell
cyclerel
gene
inhibit
forkhead
transcript
factor
foxo
critic
prolifer
cml
cell
process
result
activ
akt
signal
trigger
bcrabl
moreov
shown
pathway
play
vital
role
mainten
cml
lic
clathrin
adaptor
protein
also
known
adhesionrespons
phosphoprotein
play
import
role
cell
adhes
notabl
report
modul
signal
cancer
cell
taken
togeth
might
also
exert
function
cml
lic
follow
ato
drug
treatment
via
involv
cell
adhes
present
studi
two
gene
specif
timeseri
gene
ato
group
differ
express
pattern
profil
increasingdecreas
compar
two
group
suggest
two
gene
might
exert
function
immedi
ato
administr
due
increas
express
function
might
attenu
time
due
decreas
express
importantli
significantli
enrich
posit
regul
cell
adhes
function
suggest
ato
might
influenc
express
gene
involv
cell
cycl
cell
adhes
therebi
elimin
tki
resist
cml
cell
timeseri
gene
group
close
relat
energi
metabol
cellular
carbohydr
metabol
process
gene
show
similar
express
pattern
profil
stableincreasingdecreas
indic
timeseri
gene
administr
might
work
first
littl
durat
might
exert
function
likewis
function
might
weaken
time
cellular
carbohydr
metabol
process
essenti
tumor
cell
owe
vigor
prolifer
novel
aminopyrimidin
inhibitor
bcrabl
imatinibsensit
imatinibresist
cml
particular
show
potent
activ
imatinibresist
cml
owe
quantit
alter
bcrabl
protein
activ
site
process
extens
cellular
carbohydr
metabol
might
involv
understand
follow
treatment
alter
gene
significantli
enrich
metabol
process
base
previou
find
result
enrich
analysi
infer
might
influenc
energi
metabol
gene
involv
process
might
use
target
imatinibresist
cml
therapi
combin
ato
demonstr
synergist
effect
cml
treatment
addit
base
present
enrich
analysi
observ
timeseri
gene
group
markedli
differ
ato
group
suggest
therapi
might
differ
effect
gene
express
function
compar
group
timeseri
gene
group
express
pattern
similar
profil
stableincreasingst
highli
correl
regul
cell
prolifer
express
trend
suggest
follow
treatment
timeseri
gene
might
need
short
time
respons
drug
notabl
respons
drug
might
function
throughout
remain
time
durat
aberr
sever
gene
report
impact
cell
prolifer
cml
cell
line
overexpress
decreas
prolifer
enhanc
sensit
imatinib
moreov
increas
express
could
directli
inhibit
cell
prolifer
cml
cell
addit
compar
ato
group
timeseri
gene
express
pattern
profil
increasingstableincreas
significantli
relat
serin
famili
amino
acid
metabol
process
express
pattern
indic
timeseri
gene
trend
might
immedi
respons
combin
treatment
might
inact
function
gene
might
recov
adaptor
relat
protein
complex
mu
subunit
belong
famili
adaptor
complex
medium
subunit
reportedli
involv
antigen
process
mhc
class
pathway
human
monocyt
monocyt
could
deriv
dendrit
cell
dc
blood
cml
patient
notabl
imatinib
could
impair
gener
matur
dc
normal
monocyt
provid
hint
combin
therapi
might
also
block
dc
format
similar
imatinib
suggest
gene
relat
antigen
process
might
also
alter
treatment
collect
therapi
might
caus
alter
gene
involv
cell
prolifer
process
serin
famili
amino
acid
metabol
antigen
process
mhc
class
pathway
imatinibresist
cml
cell
although
perform
comprehens
timeseri
analysi
studi
certain
limit
first
sampl
size
rel
small
one
sampl
present
group
time
point
second
interv
sampl
time
point
equidist
might
caus
error
express
pattern
graph
gener
stem
softwar
third
gene
express
experi
valid
conclus
timeseri
gene
imatinibresist
cml
cell
line
three
treatment
differ
biolog
function
ato
treatment
might
influenc
cell
cycleand
cell
adhesionrel
gene
might
affect
gene
involv
cellular
carbohydr
metabol
combin
therapi
might
regul
gene
involv
cell
prolifer
antigen
process
function
howev
experiment
valid
need
confirm
result
